These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34137667)

  • 1. Hidradenitis Suppurativa From a Patient Perspective Including Symptoms and Self-Treatment.
    Huang CM; Kirchhof MG
    J Cutan Med Surg; 2021; 25(6):591-597. PubMed ID: 34137667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
    Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
    Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Pain on Reduced Quality of Life in Patients with Hidradenitis Suppurativa: A Single-Center Retrospective Study.
    Li Y; Speck P; Viera E; Siira M; Orenstein LAV
    Dermatology; 2023; 239(6):1007-1012. PubMed ID: 37717562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
    Johnston L; Dupuis E; Lam L; Poelman S
    J Cutan Med Surg; 2023; 27(5):487-492. PubMed ID: 37489915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and Clinical Features of Hidradenitis Suppurativa in Turkey.
    Yüksel M; Basım P
    J Cutan Med Surg; 2020; 24(1):55-59. PubMed ID: 31698918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
    Pavon Blanco A; Turner MA; Petrof G; Weinman J
    Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015.
    Heudens S; Sarkis AS; Daoud M; Daxhelet M; Benhadou F; Suppa M; Nobile L; Karama J; Njimi H; White JM; Del Marmol V
    Dermatology; 2024; 240(4):553-564. PubMed ID: 38621365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the psychological burden of patients with hidradenitis suppurativa.
    Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
    Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boils at Frictional Locations in a Patient with Hidradenitis Suppurativa.
    Boer J; Mihajlovic D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):303-304. PubMed ID: 28128084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria.
    Anaba EL; Bouazzi D; Ajayi PV; Aro OO; Boer J; Jemec GBE
    Dermatology; 2023; 239(5):832-835. PubMed ID: 37343527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
    Balcere A; Upeniece I; Snipe K; Jezupovs A
    Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.